IMNN

SEC source: 0001437749-26-018548 · rdgdoc.xml · nonDerivative · entry 1

Braun Donald P · CIK 0001661392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,319

F1 · shares: Stock granted in lieu of cash for portion of board fees

SEC source: 0001437749-26-018546 · rdgdoc.xml · nonDerivative · entry 1

Fritz Frederick J. · CIK 0001525250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,097

F1 · shares: Stock granted in lieu of cash for portion of board fees.

SEC source: 0001437749-26-018545 · rdgdoc.xml · nonDerivative · entry 1

Lindborg Stacy · CIK 0001813667 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,642

F1 · shares: Stock granted in lieu of cash for portion of base salary

SEC source: 0001437749-26-000615 · rdgdoc.xml · derivative · entry 1

Bragg Kimberly · CIK 0001814159 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,050

Underlying: Common Stock · 9,050 shares

Expires 2036-01-02

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-26-000613 · rdgdoc.xml · derivative · entry 1

Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,736

Underlying: Common Stock · 15,736 shares

Expires 2036-01-02

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-26-000611 · rdgdoc.xml · derivative · entry 1

Fritz Frederick J. · CIK 0001525250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,892

Underlying: Common Stock · 5,892 shares

Expires 2036-01-02

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-26-000610 · rdgdoc.xml · derivative · entry 1

Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,667

Underlying: Common Stock · 12,667 shares

Expires 2036-01-02

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-26-000609 · rdgdoc.xml · derivative · entry 1

Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,251

Underlying: Common Stock · 8,251 shares

Expires 2036-01-02

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-26-000608 · rdgdoc.xml · derivative · entry 1

Pellizzari Christine A · CIK 0001127430 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,827

Underlying: Common Stock · 4,827 shares

Expires 2036-01-02

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-26-000607 · rdgdoc.xml · derivative · entry 1

Braun Donald P · CIK 0001661392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,881

Underlying: Common Stock · 5,881 shares

Expires 2036-01-02

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-26-000606 · rdgdoc.xml · derivative · entry 1

Dentzer James E · CIK 0001400977 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,405

Underlying: Common Stock · 4,405 shares

Expires 2036-01-02

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-26-000605 · rdgdoc.xml · derivative · entry 1

Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,821

Underlying: Common Stock · 43,821 shares

Expires 2036-01-02

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-26-000604 · rdgdoc.xml · derivative · entry 1

Lindborg Stacy · CIK 0001813667 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,187

Underlying: Common Stock · 56,187 shares

Expires 2036-01-02

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-028685 · rdgdoc.xml · derivative · entry 3

Lindborg Stacy · CIK 0001813667 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock share represents a contingent right to receive one share of Imunon, Inc.'s common stock.

F3 · derivative.exercise_date: On September 6, 2024, Ms. Lindborg received restricted stock representing 1,667 shares (as adjusted for the reverse stock split) subject to a one-year vesting schedule, vesting 100% on the first anniversary of the grant date. As restricted stock shares vest, the vested shares are automatically converted to vested common stock on a one-for-one basis on the vesting date.

F3 · derivative.expiration_date: On September 6, 2024, Ms. Lindborg received restricted stock representing 1,667 shares (as adjusted for the reverse stock split) subject to a one-year vesting schedule, vesting 100% on the first anniversary of the grant date. As restricted stock shares vest, the vested shares are automatically converted to vested common stock on a one-for-one basis on the vesting date.

SEC source: 0001437749-25-028685 · rdgdoc.xml · nonDerivative · entry 1

Lindborg Stacy · CIK 0001813667 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,584

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Acquisition of common stock resulting from vesting of 100% of the restricted stock granted to Ms. Lindborg on September 6, 2024.

SEC source: 0001437749-25-025102 · rdgdoc.xml · derivative · entry 2

Dentzer James E · CIK 0001400977 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250

Underlying: Common Stock · 250 shares

Expires 2035-08-04

F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F3 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-025102 · rdgdoc.xml · nonDerivative · entry 1

Dentzer James E · CIK 0001400977 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,318

F1 · shares: Stock granted in lieu of cash for portion of board fees

SEC source: 0001437749-25-025100 · rdgdoc.xml · derivative · entry 2

Pellizzari Christine A · CIK 0001127430 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250

Underlying: Common Stock · 250 shares

Expires 2035-08-04

F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F3 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-025100 · rdgdoc.xml · nonDerivative · entry 1

Pellizzari Christine A · CIK 0001127430 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,248

F1 · shares: Stock granted in lieu of cash for portion of board fees

SEC source: 0001437749-25-025098 · rdgdoc.xml · derivative · entry 2

Braun Donald P · CIK 0001661392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250

Underlying: Common Stock · 250 shares

Expires 2035-08-04

F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F3 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-025098 · rdgdoc.xml · nonDerivative · entry 1

Braun Donald P · CIK 0001661392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,747

F1 · shares: Stock granted in lieu of cash for portion of board fees

SEC source: 0001437749-25-025094 · rdgdoc.xml · derivative · entry 2

Fritz Frederick J. · CIK 0001525250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250

Underlying: Common Stock · 250 shares

Expires 2035-08-04

F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F3 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-025094 · rdgdoc.xml · nonDerivative · entry 1

Fritz Frederick J. · CIK 0001525250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,946

F1 · shares: Stock granted in lieu of cash for portion of board fees.

SEC source: 0001437749-25-025091 · rdgdoc.xml · derivative · entry 1

Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,667

Underlying: Common Stock · 1,667 shares

Expires 2035-08-04

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-025090 · rdgdoc.xml · derivative · entry 1

Bragg Kimberly · CIK 0001814159 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 667

Underlying: Common Stock · 667 shares

Expires 2035-08-04

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-025089 · rdgdoc.xml · derivative · entry 1

Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 417

Underlying: Common Stock · 417 shares

Expires 2035-08-04

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-025087 · rdgdoc.xml · derivative · entry 1

Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,667

Underlying: Common Stock · 1,667 shares

Expires 2035-08-04

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-025084 · rdgdoc.xml · derivative · entry 1

Lindborg Stacy · CIK 0001813667 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2035-08-04

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-008268 · rdgdoc.xml · derivative · entry 1

Fritz Frederick J. · CIK 0001525250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2035-03-14

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-008267 · rdgdoc.xml · derivative · entry 1

Braun Donald P · CIK 0001661392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2035-03-14

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-008266 · rdgdoc.xml · derivative · entry 1

Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 6,250 shares

Expires 2035-03-14

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-008263 · rdgdoc.xml · derivative · entry 1

Dentzer James E · CIK 0001400977 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2035-03-14

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-008260 · rdgdoc.xml · derivative · entry 1

Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2035-03-14

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-008259 · rdgdoc.xml · derivative · entry 1

Pellizzari Christine A · CIK 0001127430 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2035-03-14

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-008256 · rdgdoc.xml · derivative · entry 1

Lindborg Stacy · CIK 0001813667 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2035-03-14

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-25-004366 · rdgdoc.xml · derivative · entry 1

Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2035-02-18

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options shall vest and become exercisable as to 1/4 on the one year anniversary of the grant date and each remaining 1/4 on the second, third and fourth year anniversary of the grant date, subject to the grantee's continued service as an employee through each applicable vesting date.

SEC source: 0001437749-24-037954 · rdgdoc.xml · derivative · entry 1

Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2034-12-18

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-24-030886 · rdgdoc.xml · derivative · entry 1

Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-10-07

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2 · derivative.exercise_date: The options vest as follows 1/4 on the one year anniversary of the grant and 1/4 on the second, third and fourth year anniversary.

SEC source: 0001437749-24-028885 · rdgdoc.xml · derivative · entry 1

Braun Donald P · CIK 0001661392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,905

Underlying: Imunon, Inc. Common Stock · 6,072 shares

Expires 2034-09-06

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F3 · shares: Option granted in lieu of cash for portion of board fees.

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-24-028883 · rdgdoc.xml · derivative · entry 1

Pellizzari Christine A · CIK 0001127430 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,630

Underlying: Common Stock · 4,964 shares

Expires 2034-09-06

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F3 · shares: Option granted in lieu of cash for portion of board fees.

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-24-028881 · rdgdoc.xml · derivative · entry 1

Dentzer James E · CIK 0001400977 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,301

Underlying: Common Stock · 3,634 shares

Expires 2034-09-06

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F3 · shares: Option granted in lieu of cash for portion of board fees.

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-24-028879 · rdgdoc.xml · derivative · entry 1

Fritz Frederick J. · CIK 0001525250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,070

Underlying: Common Stock · 6,737 shares

Expires 2034-09-06

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F3 · shares: Option granted in lieu of cash for portion of board fees.

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-24-028877 · rdgdoc.xml · derivative · entry 1

Lindborg Stacy · CIK 0001813667 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 302,768

Underlying: Common Stock · 63,602 shares

Expires 2034-09-06

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F3 · shares: Option granted in lieu of cash payment increases.

F2 · derivative.exercise_date: The options vest as follows 1/2 on the date of grant; 1/4 on the one year anniversary of the grant; and 1/4 on the second anniversary of the date of grant.

SEC source: 0001437749-24-028875 · rdgdoc.xml · derivative · entry 1

Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 394,759

Underlying: Common Stock · 82,926 shares

Expires 2034-09-06

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F3 · shares: Option granted in lieu of cash payment increases.

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-24-028872 · rdgdoc.xml · derivative · entry 1

Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,486

Underlying: Common Stock · 40,653 shares

Expires 2034-09-06

F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F3 · shares: Option granted in lieu of cash payment increases.

F1 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

SEC source: 0001437749-24-032858 · rdgdoc.xml · derivative · entry 1

Lindborg Stacy · CIK 0001813667 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires not disclosed

F1 · derivative.exercise_price: This amendment reports a new transaction that was inadvertently omitted from the Form 4 filed on September 10, 2024 by the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of Imunon, Inc.'s common stock.

F2 · derivative.exercise_date: On September 6, 2024, Ms. Lindborg received restricted stock units representing 25,000 shares subject to a one-year vesting schedule, vesting 100% on the first anniversary of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.

F2 · derivative.expiration_date: On September 6, 2024, Ms. Lindborg received restricted stock units representing 25,000 shares subject to a one-year vesting schedule, vesting 100% on the first anniversary of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.

SEC source: 0001437749-25-002027 · rdgdoc.xml · nonDerivative · entry 1

Braun Donald P · CIK 0001661392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,597

F1 · shares: The shares were purchased on the open market.

SEC source: 0001437749-24-027060 · rdgdoc.xml · nonDerivative · entry 1

Lindborg Stacy · CIK 0001813667 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 264,166

F1 · shares: The CEO and president purchased the shares on the open market.

SEC source: 0001437749-24-027058 · rdgdoc.xml · nonDerivative · entry 1

Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 353,346

F1 · shares: The Chairman purchased the stock on the open market.

SEC source: 0001437749-24-020266 · rdgdoc.xml · derivative · entry 1

Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 328,346

Underlying: Common Stock · 100,000 shares

Expires 2034-06-12

F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.